RE:Get the latest on GCAC! What a great letter!!
On April 30 2021, we announced an Initial Profile Analyst Report released and published by WallStreet Research™ (WSR), a top-ranked independent research firm with a history spanning over four decades. WallStreet Research™ is ranked Number One on the Google, Yahoo and Bing search engines for both small and micro-cap research with a global following. Now WSR has created an updated report, https://wallstreetresearch.org/reports/GCAC-Profile.pdf, that highlights the truly capture what the Company represents including recent accomplishments, new contracts awarded and the growth plan for the next several years. Mr. Alan Stone, CEO of WallStreet Research™ has stated: “We are pleased to announce this report coverage on Global Cannabis Applications Corp., an emerging provider of proprietary data technologies and applications for the global medical cannabis industry. The report was thoroughly researched and prepared by our top ranked technology and cannabis analyst team. We believe that GCAC is bringing innovative patented technology and software Apps to the medical cannabis industry”. Highlights of the Update Report GCAC to launch sales initiative for SME cultivators Q1 2021 balance sheet improvements Licensing agreements which identify significant future revenues Global medical cannabis market continues to grow GCAC Token adds new investors on Uniswap and Pancakeswap Recent stock trends show improvement as related to perceived shorts In the last seven months GCAC has seen dynamic growth in all aspects of its business. At the same time, we have all recently seen the downside of unwanted attention and the affect that can have, especially our loyal investors. We believe that this report encapsulates the true opportunity of the company and provides a strong reminder of what our primary focus is - helping create better outcomes for medical cannabis patients. Best regards, Brad Moore, CEO Global Cannabis Applications Corp.[/quote]